USC President C. L. Max Nikias wins 2018 SBMT Humanitarian Award

C. L. Max Nikias

USC President C. L. Max Nikias won the 2018 Society for Brain Mapping & Therapeutics Humanitarian Award. Click to watch testimony from Dr. Gary K. Michelson, founder of the Michelson Medical Research Foundation, Dr. Steve Kay, USC’s Director of Convergent Biosciences, and many others including USC trustees, deans, and world-renowned researchers. (April 20, 2018)

Scientists launch global effort to find the next diabetes drug

Illustration/Yekaterina Kadyshevskaya

USC News writes that researchers from the Bridge Institute at the USC Michelson Center for Convergent Bioscience have launched a massive effort to construct a detailed, virtual 3-D model of the pancreatic beta cell and its components — a global project that aims to one day curb the worldwide rise of diabetes. (March 23, 2018)

Metal-detection technique inspires USC cancer researchers

Peter Kuhn

USC News writes: “By imaging metal-tagged antibodies on biopsies from a patient with metastatic prostate cancer, Bridge Institute researchers at the USC Michelson Center for Convergent Bioscience have created highly detailed, digital facsimiles of cancer cells that can travel through the body.” (February 28, 2018)

USC research helps stem cell experts develop kidney treatments, reduce dialysis

USC News highlighted work by Carl Kesselman and his team, who created DERIVA (Discovery Environment for Relational Information and Versioned Assets), a software program that collects data from microscopes and organizes it and other data into virtual photo albums that easily can be shared with other researchers. Their work is part of a three-study series published on Feb. 15 in the Journal of the American Society of Nephrology. (February 15, 2018)

USC, Agilent Technologies to open center

Daily Trojan reports that Agilent Technologies announced a new collaboration with the USC Michelson Center for Convergent Bioscience to develop an Agilent Center of Excellence in Biomolecular Characterization. The Agilent CoE, which will be housed in Michelson Hall, will provide students and local customers with access to scientific researchers, Agilent instrumentation and technologies all in one scientific environment. (January 30, 2018)

‘An unprecedented year of new buildings’ at USC

USC News looks back on the year in construction at USC, highlighting the USC Village and Michelson Hall, home of the USC Michelson Center for Convergent Bioscience, as two projects that “will leave lasting impacts on future generations of Trojans and scientific research.” (December 26, 2017)

How a tumor grows can predict response to cancer therapy

USC Viterbi News writes about a new study out of the USC Viterbi School of Engineering that finds tumor growth properties can influence response to cancer drugs. “Identifying a measurement or quantity that predicts how specific tumors will respond, called a predictive biomarker, is extremely valuable to cancer research,” said Stacey Finley, a USC assistant professor of Biomedical Engineering, co-author to the study, the Gordon S. Marshall Early Career Chair, and a faculty member at the USC Michelson Center for Convergent Bioscience. (December 21, 2017)

Michelson Center researchers advance work on nonaddictive opioid painkiller

USC News writes: “What if scientists could develop an opioid-based painkiller that is not addictive and has limited side effects? That is possible based on new findings by an international team of scientists that included contributions from top researchers at the USC Michelson Center for Convergent Bioscience … The findings were published Jan. 4 in the journal Cell. They are an example of how USC Michelson Center scientists collaborate with a range of experts in multiple disciplines to conduct groundbreaking research.” (January 4, 2018)